Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Orchestra BioMed and ...

Preliminary results from Phase 1 data for LB2102 to reinforce early evidence of activity in solid tumors in a rapid oral presentation New data ...

Rather than relying on technological novelty, emerging biotechs must leverage strategic content and marketing intelligence to ...

Jorge Posada travelled from Toronto to have his art reproduced at TR Trades Reproduction in Vancouver. For more than five ...

Restaurant culture in Calgary is hot stuff these days. Our city’s restaurants and bars made a mark on recent award lists like ...

A San Francisco biotech start-up races sex cells on tiny tracks. Can an internet joke become a serious business?

Use these 10 AI writing prompts to review drafts, cut fluff, improve tone, strengthen openings, refine SEO, and polish final ...

Seven executives of shipping container companies, including Singaporean shipping veteran Teo Siong Seng, have been accused by ...

Orchestra BioMed (Nasdaq:OBIO) announced updated expectations for the timeline of its BACKBEAT cardiac pacing clinical trial.

Across Los Angeles, groups like the Smellers Club, Reverie of Scent and Silverlake Scent Club are transforming what was once ...

Q4 2026 Earnings Call May 21, 2026 4:30 AM EDTCompany ParticipantsNathan Coe - CEO & Executive DirectorJamie Warner - ...